Giorgio V. Scagliotti

Also affiliated with University of Turin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “New Approaches to SCLC Therapy: From the Laboratory to the Clinic”.

New Approaches to SCLC Therapy: From the Laboratory to the Clinic

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.016

N/A

5.4DataRank · unranked

178 citations

Julie George, Taofeek K. Owonikoko, Anton Berns, Élisabeth Brambilla, Lauren A. Byers +42 more

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.06.017

N/A

0.975DataRank · unranked

662 citations

Philip C. Mack, Giorgio V. Scagliotti, Charu Aggarwal, Maria E. Arcila, Fabrice Barlési +23 more

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.005

N/A

0.922DataRank · unranked

466 citations

Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf +38 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0.787DataRank · unranked

189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions

OncoTargets and Therapy(2018)10.2147/ott.s153764

N/A

0.661DataRank · unranked

81 citations

Clizia Zichi, Consuelo Buttigliero, Francesca Vignani, Giorgio V. Scagliotti, Massimo Di Maïo +1 more

The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.08.016

N/A

0.449DataRank · unranked

19 citations

Murry W. Wynes, Casey Connolly, Kazuto Ashizawa, Sukhinder Atkar-Khattra, Chandra P. Belani +25 more

Natural History and Real-World Treatment Outcomes for Patients With NSCLC Having EGFR Exon 20 Insertion Mutation: An International Association for the Study of Lung Cancer–American Society of Clinical Oncology CancerLinQ Study

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100592

N/A

0.312DataRank · unranked

7 citations

Renjian Jiang, Zhonglu Huang, Becky Bunn, Murry W. Wynes, Jeffrey M. Switchenko +4 more

Biomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery Data

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100816

N/A

0DataRank · unranked

0 citations

Gregory J. Joseph, Manali Rupji, Zhonglu Huang, Becky Bunn, Murry W. Wynes +7 more

Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1316

N/A

0DataRank · unranked

39 citations

Tahseen H. Nasti, Daniel Y. Chang, Masao Hashimoto, Sakshi Malik, Daniel T. McManus +16 more